Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma. 2020

Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung.

For the treatment of huge unresectable hepatocellular carcinoma (HCC), transcatheter arterial chemoembolization (TACE) or transcatheter arterial embolization (TAE) generally had poor effects and high complication rates. Our previous study found that Hepatic arterial infusion chemotherapy (HAIC) is a safe procedure and provides better survival than symptomatic treatment for the patients with huge unresectable HCC. The aim of the study is to compare the effect of HAIC vs TAE in patients with huge unresectable HCC.Since 2000 to 2005, patients with huge (size > 8 cm) unresectable HCC were enrolled. Twenty-six patients received HAIC and 25 patients received TAE. Each patient in the HAIC group received 2.5 + 1.4 (range: 1-6) courses of HAIC and in the TAE group received 1.8 + 1.2 (range: 1-5) courses of TAE. Baseline characteristics and survival were compared between the HAIC and TAE group.The HAIC group and the TAE group were similar in baseline characteristics and tumor stages. The overall survival rates at 1 and 2 years were 42% and 31% in the HAIC group and 28% and 24% in the TAE group. The patients in the HAIC group had higher overall survival than the TAE group (P = .077). Cox-regression multivariate analysis revealed that HAIC is the significant factor associated with overall survival (relative risk: 0.461, 95% confidence interval: 0.218-0.852, P = .027). No patients died of the complications of HAIC but three patients (12%) died of the complications of TAE.In conclusion, HAIC is a safe procedure and provides better survival than TAE for patients with huge unresectable HCCs.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006499 Hepatic Artery A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. Arteries, Hepatic,Artery, Hepatic,Hepatic Arteries
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
January 2014, PloS one,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
May 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
January 1990, Cardiovascular and interventional radiology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
May 1999, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
January 2021, Frontiers in oncology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
March 2012, Japanese journal of clinical oncology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
June 2020, World journal of gastrointestinal oncology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
January 1983, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
March 2024, Academic radiology,
Wei-Lun Tsai, and Wei-Chi Sun, and Wen-Chi Chen, and Chia-Ling Chiang, and Huey-Shyan Lin, and Huei-Lung Liang, and Jin-Shiung Cheng
January 1991, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!